Order Article Reprints

Qu S, Timmermans AM, Heemskerk-Gerritsen BAM, Trapman-Jansen AMAC, Broeren-Foekens R, Prager-van der Smissen WJC, El Hassnaoui H, van Tienhoven T, Bes-Stobbe CK, Westenend PJ, et al. Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation. Cancers. 2024; 16(1):28. https://doi.org/10.3390/cancers16010028

Qu, Shuoying, A. Mieke Timmermans, Bernadette A. M. Heemskerk-Gerritsen, Anita M. A. C. Trapman-Jansen, Renée Broeren-Foekens, Wendy J. C. Prager-van der Smissen, Hoesna El Hassnaoui, Tim van Tienhoven, Claudia K. Bes-Stobbe, Pieter J. Westenend, and et al. 2024. "Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation" Cancers 16, no. 1: 28. https://doi.org/10.3390/cancers16010028

Qu, S., Timmermans, A. M., Heemskerk-Gerritsen, B. A. M., Trapman-Jansen, A. M. A. C., Broeren-Foekens, R., Prager-van der Smissen, W. J. C., El Hassnaoui, H., van Tienhoven, T., Bes-Stobbe, C. K., Westenend, P. J., van Deurzen, C. H. M., Martens, J. W. M., Hooning, M. J., & Hollestelle, A. (2024). Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation. Cancers, 16(1), 28. https://doi.org/10.3390/cancers16010028